Covid‐19 vaccines and variants of concern: a review
I Hadj Hassine - Reviews in medical virology, 2022 - Wiley Online Library
Since the outbreak of coronavirus disease 2019 (Covid‐19) in December 2019, caused by
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
T Fiolet, Y Kherabi, CJ MacDonald, J Ghosn… - Clinical Microbiology …, 2022 - Elsevier
Background Vaccines are critical cost-effective tools to control the coronavirus disease 2019
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …
(COVID-19) pandemic. However, the emergence of variants of the severe acute respiratory …
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
B Zeng, L Gao, Q Zhou, K Yu, F Sun - BMC medicine, 2022 - Springer
Background It was urgent and necessary to synthesize the evidence for vaccine
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies
W Gong, S Parkkila, X Wu… - International reviews of …, 2023 - Taylor & Francis
The ongoing COVID-19 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has become a global threat. Despite strict control measures …
coronavirus 2 (SARS-CoV-2) has become a global threat. Despite strict control measures …
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape
JS Tregoning, KE Flight, SL Higham, Z Wang… - Nature reviews …, 2021 - nature.com
Where 2020 saw the development and testing of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …
syndrome coronavirus 2 (SARS-CoV-2) at an unprecedented pace, the first half of 2021 has …
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Abstract Coronavirus Disease 2019 (COVID-19) has been the most severe public health
challenge in this century. Two years after its emergence, the rapid development and …
challenge in this century. Two years after its emergence, the rapid development and …
COVID-19 vaccines: concerns beyond protective efficacy and safety
Introduction Several vaccine candidates have been developed using different platforms,
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
including nucleic acids (DNA and RNA), viral vectors (replicating and non-replicating), virus …
A review of the safety and efficacy of current COVID-19 vaccines
Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
A novel coronavirus, which has been designated as severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
coronavirus 2 (SARS-CoV-2), was first detected in December 2019 in Wuhan China and …
Vaccine versus variants (3Vs): are the COVID-19 vaccines effective against the variants? A systematic review
Background: With the emergence and spread of new SARS-CoV-2 variants, concerns are
raised about the effectiveness of the existing vaccines to protect against these new variants …
raised about the effectiveness of the existing vaccines to protect against these new variants …